Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Mosaic ImmunoEngineering Inc.

Get SEC filing alerts via email and in your feed for Mosaic ImmunoEngineering Inc.

CPMV

Mosaic ImmunoEngineering Inc.

About Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering is a biotechnology company focused on developing immunotherapies for cancer treatment. It aims to identify, license, and acquire innovative product candidates and platforms, leveraging expertise in immuno-oncology. The company explores novel therapies, including AI-driven combination strategies, with a pipeline primarily in early-stage preclinical development, targeting unmet medical needs in oncology markets worldwide.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Mosaic ImmunoEngineering Inc.

1
1
Mosaic ImmunoEngineering Inc. Mosaic ImmunoEngineering Reports Improved Net Loss of $175,351 for Q1 2026

Via official filing (AI summary) | 14 days ago | 0 comments

2
1
Mosaic ImmunoEngineering Inc. Mosaic ImmunoEngineering Reports $687,846 Net Loss and Urgent Funding Needs

Via official filing (AI summary) | about 2 months ago | 0 comments

3
1
Mosaic ImmunoEngineering Inc. Mosaic ImmunoEngineering Reports Decreased Net Loss and Financial Challenges in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Mosaic ImmunoEngineering Inc. Mosaic ImmunoEngineering Reports Decreased Net Losses and Focus on Cost Management

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Mosaic ImmunoEngineering Inc. Mosaic ImmunoEngineering Reports Improved Net Loss and Decreased Operating Expenses in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Mosaic ImmunoEngineering Inc. Mosaic ImmunoEngineering Reports Financial Challenges, Net Loss, and Liquidity Concerns

Via official filing (AI summary) | over 1 year ago | 0 comments